© 2000 by Oxford University Press
Journal of the National Cancer Institute, Vol. 92, No. 23, 1879-1880,
December 6, 2000
© 2000 Oxford University Press
NEWS |
Awards, Appointments, Announcements
The Cure for Lymphoma Foundation, New York, presented four awards at its Sixth Annual Cabaret for the Cure in November.Ronald Levy, M.D., of the Stanford University School of Medicine, Palo Alto, Calif., received the Key to the Cure Award for his research on a lymphoma vaccine. Morton Coleman, M.D., of the Weill Medical College of Cornell University and the New York Presbyterian Hospital, received the Together Award, which honors his role as a clinician.
Gary M. Reedy, president of Ortho Biotech, accepted the Trailblazer Award for cancer research excellence. Gwen Darien, editor of MAMM magazine, was honored with the LymphomADVOCACY award for efforts to raise awareness of the rising incidence of lymphoma.
Siegfried Honored
Jill Marie Siegfried, Ph.D., received the 15th Annual Alton Ochsner Award Relating Smoking and Health at the annual convention of the American College of Chest Physicians in October.
Siegfried is a professor and vice chairman of the Department of Pharmacology at the University of Pittsburgh School of Medicine and codirector of the Lung Cancer Program at the University of Pittsburgh Cancer Institute.
Her research focuses on the cellular and molecular aspects of lung cancer. She has developed methods to study the biologic changes that occur in human lung tumors.
Quality of Life Awards Presented
The International Myeloma Foundation recently presented its Quality of Life Awards at a fund-raising event in New York City. The recipients were:
• John Seaman, executive director of clinical research at Novartis Pharmaceuticals, honored for his role in bringing bisphosphonates to market;
• Werner Osterwalder, global brand manager for Novartis, honored for helping the International Myeloma Foundation present patient and family seminars to an international audience;
• John Jackson, chairman and chief executive officer of Celgene Corp., honored for his studies of thalidomide in myeloma patients in clinical trials; and
• Herbert Fleisch, University of Berne, Switzerland, who was honored for discovering that bisphosphonates play a role in inhibiting bone destruction.
Hammond Honored
G. Denman Hammond, M.D., has been named Cancer Fighter of the Year by the Beckstrand Cancer Foundation, Long Beach, Calif.
|
Hammond was honored for his leadership in the research and treatment of childhood cancer. He served as chairman of the Children’s Cancer Group for 24 years, and later founded the National Childhood Cancer Foundation, Arcadia, Calif. He has also served as vice president of the American Cancer Society and presidential appointee to the National Cancer Advisory Board.
Pfizer Gives Award
Constantino Benedetti, M.D., director of cancer pain and palliative medicine at Ohio State University’s Arthur G. James Cancer Hospital and Richard J. Solove Research Insitute, Columbus, Ohio, received the 2000 Quality of Care Award from Pfizer Inc.
Benedetti was honored for his lifetime contribution to the field of pain control and palliative care. Pfizer presents the award to health care professionals who have demonstrated outstanding leadership, integrity, and community service.
Strang Award Given
V. Craig Jordan, Ph.D., D.Sc., was presented with the Strang Award from the Strang Cancer Prevention Center, Weill Medical College of Cornell University, New York.
Jordan is the Diana, Princess of Wales Professor of Cancer Research at Northwestern University in Chicago. He was honored for his work that resulted in the use of tamoxifen and raloxifene for the chemoprevention of breast cancer. Previous recipients of the award include Arnold Levine, Alfred Knudson, and Bruce Ames.
Deems Named
David M. Deems has been named the chief executive officer of Union Biometrica Inc., Somerville, Mass., which produces customized drug discovery systems.
Deems was most recently vice president of BD Biosciences, San Jose, Calif. At Union Biometrica, he will be responsible for advancing the company’s technology products for the automated screening of functional and disease model organisms and cells.
Applications Available
The Dannon Institute, Tarrytown, N.Y., is accepting applications for its Awards for Excellence in Community Nutrition.
The awards will be given to innovative and replicable programs that have made an impact in nutrition behavior at the community level. Seven community nutrition program awards of $5,000 each will be announced May 1, 2001.
The deadline for applications is Feb. 1, 2001. For more information, call the Dannon Institute at 914-332-1092.
CiteULike 
Connotea 
Del.icio.us What's this?
| ||||||||||||||||||||||||||||||||||||||||||||